German Adalimumab Biosimilars Near A Third

 
• By Aidan Fry

Biosimilar adalimumab rivals to AbbVie’s Humira blockbuster continue to take market share in Germany, the latest market data demonstrates.

Charts
Biosimilar adalimumabs are continuing to capture volume share in Germany • Source: Shutterstock

More from Biosimilars

More from Products